Inhibition of TGF-β signaling increases the anti-tumor activity of NK cells and prevents the formation of bone metastases in an experimental breast cancer model [90], but the direct effects between TGF-β and NK cells remain to be studied. This evidence concerns the gene TGFB1 and breast carcinoma.